Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

13D Filing: Wynnefield Partners and Layne Christensen Co (LAYN)

Page 1 of 15

Nelson ObusWynnefield Partners currently owns 1.70 million shares of Layne Christensen Company (NASDAQ:LAYN), as a filing with the Securities and Exchange Commission showed. The 13D filing revealed that the activist position held by Wynnefield amasses around 8.5% of Layne Christensen’s outstanding stock. Moreover, the current stake represents a considerable increase from the 320,700 shares that Wynnefield disclosed in its last 13F filing (for the end of the third quarter of 2015).

You can access the original SEC filing by clicking here.

Page 1 of 15 SEC Filing



Washington, D.C. 20549



Under the Securities Exchange Act of 1934


(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)


(CUSIP Number)

Wynnefield Partners Small Cap Value, L.P.

450 Seventh Avenue, Suite 509

New York, New York 10123

Attention: Mr. Nelson Obus

Copy to:

Jeffrey S. Tullman, Esq.

Kane Kessler, P.C.

1350 Avenue of the Americas, 26th

New York, New York 10019

(212) 541-6222

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

January 8, 2016

(Date of Event which requires Filing of
this Statement)

If the filing person has previously filed
a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because
of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [ ]

Follow Layne Christensen Co (NASDAQ:LAYN)
Trade (NASDAQ:LAYN) Now!
Page 1 of 15

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!